In addition, clinical and in vitro data revealed that GPRC6A is associated with aggressive prostate cancer, with a pivotal role in cell proliferation, migration, invasion, and Epithelial-Mesenchymal Transition (EMT) [47]. The gene discussed is GPRC6A; the disease is Familial prostate cancer.